Outcome of second‐line therapy in adult B‐cell acute lymphoblastic leukemia

Cancer 2026

View at publisher
Authors: Hagop Kantarjian, Wei Qiao, Nitin Jain, Wei‐Ying Jen, Eitan Kugler, Nicholas James Short, Rebecca Garris, Sherry Pierce, Partow Kebriaei, Sa A. Wang, Fadi Haddad, Farhad Ravandi
+2 more Xuelin Huang, Elias Joseph Jabbour
DOI: 10.1002/cncr.70401
Cited by: 1
References: 14

Abstract

BACKGROUND AND STUDY AIMS: Historically, adults with B-cell acute lymphoblastic leukemia (ALL) treated with standard intensive chemotherapy in first salvage had a complete response rate of 40% and a 3-year survival rate

Fields of Study & Subjects

Acute Lymphoblastic Leukemia research Chronic Myeloid Leukemia Treatments Chronic Lymphocytic Leukemia Research

Publication details

Journal / source
Cancer
Publisher
Wiley
Volume
132
Issue
8
Pages
e70401–e70401
Publication date
9 April 2026
Language
EN